BRIAN A MARKISON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRIAN A MARKISON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRIAN A MARKISON. BRIAN A MARKISON is Director in IMMUNOMEDICS INC ($IMMU) and Chief Operating Officer in KING PHARMACEUTICALS INC ($KG) and President & CEO in KING PHARMACEUTICALS INC ($KG) and President and CEO in KING PHARMACEUTICALS INC ($KG) and Director in ALERE INC. ($ALR) and Director in Lantheus Holdings, Inc. ($LNTH) and in Avista Healthcare Public Acquisition Corp. ($AHPA) and Director in Avista Healthcare Public Acquisition Corp. ($AHPA) and Chief Executive Officer in Osmotica Pharmaceuticals plc ($OSMT).
Latest Insider Trading Transactions of BRIAN A MARKISON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALR, IMMU, KG, LNTH, ORGO, OSMT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2020 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 2,277 | 0 | 39,275 | 37 K to 39.3 K (+6.15 %) |
| Oct 05 2020 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 2,277 | 0 | 39,275 | 37 K to 39.3 K (+6.15 %) |
| Aug 12 2020 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 1,354 | 0 | 36,998 | 35.6 K to 37 K (+3.80 %) |
| May 22 2020 | OSMT | Osmotica Pharmaceu ... | MARKISON BRIAN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 249,787 | 0 | 249,787 | |
| May 22 2020 | OSMT | Osmotica Pharmaceu ... | MARKISON BRIAN A | Chief Executive Off ... | Grant | A | 0.00 | 249,787 | 0 | 2,126,020 | 1.9 M to 2.1 M (+13.31 %) |
| Mar 05 2020 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 8,095 | 0 | 35,644 | 27.5 K to 35.6 K (+29.38 %) |
| Jul 12 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 28.07 | 4,918 | 138,048 | 27,549 | 32.5 K to 27.5 K (-15.15 %) |
| Jul 05 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 28.41 | 5,000 | 142,050 | 32,467 | 37.5 K to 32.5 K (-13.35 %) |
| Jun 28 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 27.67 | 5,000 | 138,361 | 37,467 | 42.5 K to 37.5 K (-11.77 %) |
| Jun 21 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 27.40 | 5,000 | 137,015 | 42,467 | 47.5 K to 42.5 K (-10.53 %) |
| Jun 14 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 25.27 | 5,000 | 126,365 | 47,467 | 52.5 K to 47.5 K (-9.53 %) |
| Jun 07 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 24.60 | 5,000 | 123,010 | 52,467 | 57.5 K to 52.5 K (-8.70 %) |
| May 31 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 24.29 | 5,000 | 121,454 | 57,467 | 62.5 K to 57.5 K (-8.00 %) |
| May 24 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 24.73 | 5,000 | 123,628 | 62,467 | 67.5 K to 62.5 K (-7.41 %) |
| May 17 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 24.75 | 5,000 | 123,755 | 67,467 | 72.5 K to 67.5 K (-6.90 %) |
| May 10 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 25.22 | 5,000 | 126,116 | 72,467 | 77.5 K to 72.5 K (-6.45 %) |
| May 02 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 23.91 | 5,000 | 119,537 | 77,467 | 82.5 K to 77.5 K (-6.06 %) |
| May 02 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 24.30 | 5,000 | 121,519 | 82,467 | 87.5 K to 82.5 K (-5.72 %) |
| Apr 25 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 24.07 | 5,000 | 120,368 | 87,467 | 92.5 K to 87.5 K (-5.41 %) |
| Apr 18 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Sell | S | 25.26 | 5,000 | 126,298 | 92,467 | 97.5 K to 92.5 K (-5.13 %) |
| Feb 28 2019 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 5,353 | 0 | 97,467 | 92.1 K to 97.5 K (+5.81 %) |
| Feb 27 2019 | OSMT | Osmotica Pharmaceu ... | MARKISON BRIAN A | Chief Executive Off ... | Grant | A | 0.00 | 387,991 | 0 | 1,876,233 | 1.5 M to 1.9 M (+26.07 %) |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | MARKISON BRIAN A | Option Exercise | D | 0.00 | 442,151 | 0 | 133,589 | ||
| Dec 12 2018 | AHPA | Organogenesis Hold ... | MARKISON BRIAN A | Option Exercise | D | 0.00 | 442,151 | 0 | 133,589 | ||
| Nov 01 2018 | AHPA | Avista Healthcare ... | MARKISON BRIAN A | Director | Option Exercise | J | 0.00 | 5,510 | 0 | 575,740 | |
| Oct 15 2018 | AHPA | Avista Healthcare ... | MARKISON BRIAN A | Director | Option Exercise | D | 0.00 | 193,750 | 0 | 581,250 | |
| Oct 15 2018 | AHPA | Avista Healthcare ... | MARKISON BRIAN A | Director | Option Exercise | D | 0.00 | 193,750 | 0 | 581,250 | |
| Mar 07 2018 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 7,911 | 0 | 92,114 | 84.2 K to 92.1 K (+9.40 %) |
| Nov 21 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | M | 3.16 | 15,000 | 47,400 | 0 | |
| Nov 21 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Sell | S | 11.89 | 8,390 | 99,724 | 90,788 | 99.2 K to 90.8 K (-8.46 %) |
| Nov 21 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Buy | M | 3.16 | 15,000 | 47,400 | 99,178 | 84.2 K to 99.2 K (+17.82 %) |
| Oct 03 2017 | ALR | ALERE INC. | MARKISON BRIAN A | Director | Option Exercise | D | 33.73 | 53,756 | 1,813,190 | 0 | |
| Oct 03 2017 | ALR | ALERE INC. | MARKISON BRIAN A | Director | Sell | D | 0.00 | 5,530 | 0 | 0 | 5.5 K to 0 (-100.00 %) |
| Aug 14 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | A | 0.00 | 7,051 | 0 | 7,051 | |
| Aug 14 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | A | 7.80 | 12,539 | 97,804 | 12,539 | |
| Jul 07 2017 | AHPA | Avista Healthcare ... | MARKISON BRIAN A | Option Exercise | P | 0.00 | 186,320 | 0 | 775,000 | ||
| Jul 05 2017 | ALR | ALERE INC. | MARKISON BRIAN A | Director | Option Exercise | M | 0.00 | 5,530 | 0 | 0 | |
| Jul 05 2017 | ALR | ALERE INC. | MARKISON BRIAN A | Director | Buy | M | 0.00 | 5,530 | 0 | 5,530 | 0 to 5.5 K |
| Dec 07 2016 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | M | 0.00 | 14,469 | 0 | 0 | |
| Dec 07 2016 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Payment of Exercise | F | 0.00 | 5,737 | 0 | 84,178 | 89.9 K to 84.2 K (-6.38 %) |
| Dec 07 2016 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Buy | M | 0.00 | 14,469 | 0 | 89,915 | 75.4 K to 89.9 K (+19.18 %) |
| Nov 29 2016 | AHPA | Avista Healthcare ... | MARKISON BRIAN A | Option Exercise | P | 0.00 | 161,180 | 0 | 588,680 | ||
| Nov 29 2016 | AHPA | Avista Healthcare ... | MARKISON BRIAN A | Option Exercise | D | 0.00 | 43,750 | 0 | 427,500 | ||
| Nov 17 2016 | ALR | ALERE INC. | MARKISON BRIAN A | Director | Option Exercise | A | 0.00 | 5,530 | 0 | 5,530 | |
| Aug 25 2016 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | M | 1.96 | 15,000 | 29,400 | 0 | |
| Aug 25 2016 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Sell | S | 2.98 | 15,000 | 44,634 | 75,446 | 90.4 K to 75.4 K (-16.58 %) |
| Aug 25 2016 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Buy | M | 1.96 | 15,000 | 29,400 | 90,446 | 75.4 K to 90.4 K (+19.88 %) |
| Mar 08 2016 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 25,000 | 0 | 75,473 | 50.5 K to 75.5 K (+49.53 %) |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | A | 0.00 | 14,469 | 0 | 14,469 | |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | A | 3.11 | 28,821 | 89,633 | 28,821 | |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | M | 0.00 | 10,664 | 0 | 0 | |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | M | 1.59 | 15,000 | 23,850 | 0 | |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Payment of Exercise | F | 0.00 | 4,229 | 0 | 75,446 | 79.7 K to 75.4 K (-5.31 %) |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Buy | M | 0.00 | 10,664 | 0 | 79,675 | 69 K to 79.7 K (+15.45 %) |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Payment of Exercise | F | 3.17 | 10,488 | 33,247 | 69,011 | 79.5 K to 69 K (-13.19 %) |
| Dec 04 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Buy | M | 1.59 | 15,000 | 23,850 | 79,499 | 64.5 K to 79.5 K (+23.26 %) |
| Jun 25 2015 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Option Exercise | A | 6.00 | 16,666 | 99,996 | 16,666 | |
| Jun 25 2015 | LNTH | Lantheus Holdings, ... | MARKISON BRIAN A | Director | Grant | A | 0.00 | 16,666 | 0 | 50,473 | 33.8 K to 50.5 K (+49.30 %) |
| Jun 15 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | M | 1.76 | 10,000 | 17,600 | 0 | |
| Jun 15 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Sell | S | 4.22 | 5,564 | 23,470 | 64,499 | 70.1 K to 64.5 K (-7.94 %) |
| Jun 15 2015 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Buy | M | 1.76 | 10,000 | 17,600 | 70,063 | 60.1 K to 70.1 K (+16.65 %) |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 12.44 | 225,130 | 2,800,617 | 0 | |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 6.97 | 250,970 | 1,749,261 | 0 | |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 8.91 | 181,590 | 1,617,967 | 0 | |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | J | 10.57 | 250,000 | 2,642,500 | 0 | |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | D | 0.00 | 95,213 | 0 | 0 | |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | D | 0.00 | 278,160 | 0 | 0 | |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Sell | D | 0.00 | 200,760 | 0 | 0 | 200.8 K to 0 (-100.00 %) |
| Feb 02 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Sell | U | 0.00 | 547,360 | 0 | 200,760 | 748.1 K to 200.8 K (-73.16 %) |
| Jan 20 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 95,213 | 0 | 95,213 | |
| Jan 20 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | M | 0.00 | 201,260 | 0 | 0 | |
| Jan 20 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Buy | M | 0.00 | 201,260 | 0 | 748,120 | 546.9 K to 748.1 K (+36.80 %) |
| Jan 11 2011 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 86,260 | 0 | 546,860 | 460.6 K to 546.9 K (+18.73 %) |
| Dec 17 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 14.22 | 92,700 | 1,318,194 | 460,600 | 553.3 K to 460.6 K (-16.75 %) |
| Mar 24 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 12.25 | 21,706 | 265,899 | 561,484 | 583.2 K to 561.5 K (-3.72 %) |
| Mar 19 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 12.44 | 225,130 | 2,800,617 | 225,130 | |
| Mar 19 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 63,790 | 0 | 583,190 | 519.4 K to 583.2 K (+12.28 %) |
| Mar 12 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 12.22 | 42,246 | 516,246 | 519,400 | 561.6 K to 519.4 K (-7.52 %) |
| Mar 04 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Sell | S | 11.72 | 69,744 | 817,679 | 561,646 | 631.4 K to 561.6 K (-11.05 %) |
| Mar 01 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 278,160 | 0 | 278,160 | |
| Jan 05 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | M | 0.00 | 108,801 | 0 | 0 | |
| Jan 05 2010 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Buy | M | 0.00 | 108,801 | 0 | 631,390 | 522.6 K to 631.4 K (+20.82 %) |
| Mar 25 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 6.97 | 250,970 | 1,749,261 | 250,970 | |
| Mar 25 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 79,470 | 0 | 522,589 | 443.1 K to 522.6 K (+17.93 %) |
| Mar 24 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 6.80 | 9,979 | 67,857 | 443,119 | 453.1 K to 443.1 K (-2.20 %) |
| Mar 12 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 6.31 | 29,454 | 185,855 | 453,098 | 482.6 K to 453.1 K (-6.10 %) |
| Feb 19 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 201,260 | 0 | 201,260 | |
| Jan 21 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | M | 0.00 | 68,580 | 0 | 0 | |
| Jan 21 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 12,448 | 0 | 482,552 | 470.1 K to 482.6 K (+2.65 %) |
| Jan 21 2009 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Buy | M | 0.00 | 68,580 | 0 | 470,104 | 401.5 K to 470.1 K (+17.08 %) |
| Sep 02 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Payment of Exercise | F | 10.15 | 60,256 | 611,598 | 401,524 | 461.8 K to 401.5 K (-13.05 %) |
| Mar 27 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 8.91 | 181,590 | 1,617,967 | 181,590 | |
| Mar 27 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 57,500 | 0 | 461,780 | 404.3 K to 461.8 K (+14.22 %) |
| Feb 22 2008 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 108,801 | 0 | 108,801 | |
| Dec 18 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 200,000 | 0 | 404,280 | 204.3 K to 404.3 K (+97.90 %) |
| Mar 23 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 19.29 | 92,110 | 1,776,802 | 92,110 | |
| Mar 23 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 46,830 | 0 | 204,280 | 157.5 K to 204.3 K (+29.74 %) |
| Feb 28 2007 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 0.00 | 68,580 | 0 | 68,580 | |
| Mar 22 2006 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Option Exercise | A | 19.68 | 53,980 | 1,062,326 | 53,980 | |
| Mar 22 2006 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 27,450 | 0 | 157,450 | 130 K to 157.5 K (+21.12 %) |
| Oct 20 2005 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President and CEO | Grant | A | 0.00 | 130,000 | 0 | 130,000 | 0 to 130 K |
| Jul 16 2004 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | President & CEO | Option Exercise | A | 10.67 | 250,000 | 2,667,500 | 250,000 | |
| Mar 09 2004 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | Chief Operating Off ... | Option Exercise | A | 19.47 | 125,000 | 2,433,750 | 125,000 | |
| Mar 09 2004 | KG | KING PHARMACEUTICA ... | MARKISON BRIAN A | Chief Operating Off ... | Option Exercise | A | 19.47 | 125,000 | 2,433,750 | 125,000 |
Page: 1